Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gwill York currently holds 10,958 shares of Alto Neuroscience, Inc. (ANRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gwill York has been a net neutral trader of ANRO stock. They have purchased $0 and sold $0 worth of shares.
Gwill York's most recent insider trade was on May 12, 2026, when they sold 10,958 shares at $0.00 per share.
Gwill York serves as Executive at Alto Neuroscience, Inc. (ANRO). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Gwill York holds the position of Executive at Alto Neuroscience, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gwill York has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gwill York was on Jan 2, 2026, when they purchased $62.0K worth of ANRO shares. This transaction involved 5,243 shares at $11.82 per share.
Gwill York currently owns 10,958 shares of Alto Neuroscience, Inc. (ANRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gwill York's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gwill York has 6 Form 4 filings on record as an insider at Alto Neuroscience, Inc..
Set alerts for Gwill York and 40,000+ other insiders.